{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:38:28Z","timestamp":1756571908064},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":822,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/jto.0b013e31829ceb6a","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T17:01:17Z","timestamp":1374771677000},"page":"1203-1211","source":"Crossref","is-referenced-by-count":20,"title":["Overexpression of EPH Receptor B2 in Malignant Mesothelioma Correlates with Oncogenic Behavior"],"prefix":"10.1016","volume":"8","author":[{"given":"Chandra","family":"Goparaju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica S.","family":"Donington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsungda","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey I.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e31829ceb6a_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2068","article-title":"A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes","volume":"7","author":"Carbone","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Carbone","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib3","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Tsao","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1568009053765780","article-title":"EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics","volume":"5","author":"Ireton","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/B:AGEN.0000037340.33788.87","article-title":"Eph receptor tyrosine kinases in angiogenesis: from development to disease","volume":"7","author":"Brantley-Sieders","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrm856","article-title":"Mechanisms and functions of Eph and ephrin signalling","volume":"3","author":"Kullander","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nrm1662","article-title":"Eph receptor signalling casts a wide net on cell behaviour","volume":"6","author":"Pasquale","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0896-6273(00)80276-7","article-title":"Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis","volume":"17","author":"Gale","year":"1996","journal-title":"Neuron"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","article-title":"Eph-ephrin bidirectional signaling in physiology and disease","volume":"133","author":"Pasquale","year":"2008","journal-title":"Cell"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ccr.2005.07.005","article-title":"A conditional feedback loop regulates Ras activity through EphA2","volume":"8","author":"Macrae","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib11","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1158\/0008-5472.CAN-06-0004","article-title":"Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin","volume":"66","author":"Guo","year":"2006","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ncb1438","article-title":"The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway","volume":"8","author":"Noren","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nature03626","article-title":"EphB receptor activity suppresses colorectal cancer progression","volume":"435","author":"Batlle","year":"2005","journal-title":"Nature"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib14","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/ng.2007.11","article-title":"EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells","volume":"39","author":"Cortina","year":"2007","journal-title":"Nat Genet"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0002-9440(10)63899-0","article-title":"Differential regulation of EphA2 in normal and malignant cells","volume":"162","author":"Walker-Daniels","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib16","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/sj.onc.1207247","article-title":"EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma","volume":"23","author":"Duxbury","year":"2004","journal-title":"Oncog"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib17","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1158\/1078-0432.CCR-05-0143","article-title":"EphB2 is a prognostic factor in colorectal cancer","volume":"11","author":"Jubb","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib18","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1158\/0008-5472.CAN-03-3667","article-title":"The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells","volume":"64","author":"Nakada","year":"2004","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1373\/clinchem.2003.026849","article-title":"Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers","volume":"50","author":"Hafner","year":"2004","journal-title":"Clin Chem"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1349-7006.2005.00007.x","article-title":"EPHA2\/EFNA1 expression in human gastric cancer","volume":"96","author":"Nakamura","year":"2005","journal-title":"Cancer Sci"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib21","first-page":"419","article-title":"Silencing receptor EphA2 induces apoptosis and attenuates tumor growth in malignant mesothelioma","volume":"1","author":"Mohammed","year":"2011","journal-title":"Am J Cancer Res"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib22","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1158\/1078-0432.CCR-04-2109","article-title":"Up-regulation of EphB4 in mesothelioma and its biological significance","volume":"11","author":"Xia","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0003-4975(95)00045-M","article-title":"Characteristics of nine newly derived mesothelioma cell lines","volume":"59","author":"Pass","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib24","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1158\/1078-0432.CCR-08-2755","article-title":"Protumorigenic role of HAPLN1 and its IgV domain in malignant pleural mesothelioma","volume":"15","author":"Ivanova","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrc2841","article-title":"Implications and challenges of connexin connections to cancer","volume":"10","author":"Naus","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/14728222.2010.487866","article-title":"Gap junctions and connexins as therapeutic targets in cancer","volume":"14","author":"Kandouz","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib27","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2741\/3726","article-title":"Tight junctions in cancer metastasis","volume":"16","author":"Martin","year":"2011","journal-title":"Front Biosci"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrc3051","article-title":"Desmosomes: new perpetrators in tumour suppression","volume":"11","author":"Dusek","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2741\/3703","article-title":"Growth Factors and their receptors in cancer metastases","volume":"16","author":"Yang","year":"2011","journal-title":"Front Biosci"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/thx.54.2.169","article-title":"The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer","volume":"54","author":"Cox","year":"1999","journal-title":"Thorax"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib31","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1054\/bjoc.2000.1445","article-title":"Hepatocyte growth factor\/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases","volume":"83","author":"Harvey","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib32","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1102>3.0.CO;2-Y","article-title":"Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines","volume":"91","author":"Liu","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib33","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.bjc.6600920","article-title":"Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura","volume":"88","author":"Edwards","year":"2003","journal-title":"Br J Cancer"},{"issue":"Pt 1","key":"10.1097\/JTO.0b013e31829ceb6a_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3260001","article-title":"Caspases: the executioners of apoptosis","volume":"326","author":"Cohen","year":"1997","journal-title":"Biochem J"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)80430-4","article-title":"Caspases: intracellular signaling by proteolysis","volume":"91","author":"Salvesen","year":"1997","journal-title":"Cell"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3748\/wjg.v8.i1.31","article-title":"Morphological and functional changes of mitochondria in apoptotic esophageal carcinoma cells induced by arsenic trioxide","volume":"8","author":"Shen","year":"2002","journal-title":"World J Gastroenterol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0092-8674(00)00008-8","article-title":"Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition","volume":"102","author":"Du","year":"2000","journal-title":"Cell"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib38","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1083\/jcb.144.5.891","article-title":"Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis","volume":"144","author":"Desagher","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(93)80066-N","article-title":"Bcl-2 functions in an antioxidant pathway to prevent apoptosis","volume":"75","author":"Hockenbery","year":"1993","journal-title":"Cell"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib40","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1074\/jbc.273.19.11401","article-title":"Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss","volume":"273","author":"Cai","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/path.2121","article-title":"Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma","volume":"211","author":"Gordon","year":"2007","journal-title":"J Pathol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib42","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.humpath.2006.12.013","article-title":"Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma","volume":"38","author":"Kleinberg","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/path.1937","article-title":"Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system","volume":"208","author":"Zhang","year":"2006","journal-title":"J Pathol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib44","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCRESAHA.108.184937","article-title":"Brothers and sisters: molecular insights into arterial-venous heterogeneity","volume":"103","author":"Aitsebaomo","year":"2008","journal-title":"Circ Res"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib45","first-page":"2858","article-title":"Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules","volume":"53","author":"Lee","year":"1993","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib46","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/bjc.1994.410","article-title":"Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha\/epidermal growth factor receptor mitogenic pathway","volume":"70","author":"M\u00f3rocz","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib47","first-page":"367","article-title":"Interleukin 8: an autocrine growth factor for malignant mesothelioma","volume":"59","author":"Galffy","year":"1999","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.bjc.6690650","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours","volume":"81","author":"Ohta","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib49","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4049\/jimmunol.159.3.1437","article-title":"The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis","volume":"159","author":"Keane","year":"1997","journal-title":"J Immunol"},{"key":"10.1097\/JTO.0b013e31829ceb6a_bib50","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"Leung","year":"1989","journal-title":"Science"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415334778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415334778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T12:24:07Z","timestamp":1688387047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415334778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1556086415334778"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e31829ceb6a","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}